Casella, V.; Cebollada Rica, P.; Argilaguet, J.; Vidal, E.; González-Cao, M.; Güerri-Fernandez, R.; Bocharov, G.; Meyerhans, A.
Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis. Viruses 2024, 16, 799.
https://doi.org/10.3390/v16050799
AMA Style
Casella V, Cebollada Rica P, Argilaguet J, Vidal E, González-Cao M, Güerri-Fernandez R, Bocharov G, Meyerhans A.
Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis. Viruses. 2024; 16(5):799.
https://doi.org/10.3390/v16050799
Chicago/Turabian Style
Casella, Valentina, Paula Cebollada Rica, Jordi Argilaguet, Enric Vidal, MarÃa González-Cao, Roberto Güerri-Fernandez, Gennady Bocharov, and Andreas Meyerhans.
2024. "Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis" Viruses 16, no. 5: 799.
https://doi.org/10.3390/v16050799
APA Style
Casella, V., Cebollada Rica, P., Argilaguet, J., Vidal, E., González-Cao, M., Güerri-Fernandez, R., Bocharov, G., & Meyerhans, A.
(2024). Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis. Viruses, 16(5), 799.
https://doi.org/10.3390/v16050799
